Safety and Health at Work

  • 제10권3호
  • /
  • Pages.362-369
  • /
  • 2019
  • /
  • 2093-7911(pISSN)
  • /
  • 2093-7997(eISSN)
산업안전보건연구원 (Occupational Safety and Health Research Institute, Korea Occupational Safety and Health Agency)
권호 표지
DOI QR코드

DOI QR Code

Clinical Characteristics of Disability in Patients with Indoor Aire-Related Environmental Intolerance

  • 투고 : 2019.04.06
  • 심사 : 2019.06.06
  • 발행 : 2019.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Chronic nonspecific symptoms attributed to indoor nonindustrial work environments are common and may cause disability, but the medical nature of this disability is unclear. The aim was to medically characterize the disability manifested by chronic, recurrent symptoms and restrictions to work participation attributed to low-level indoor pollutants at workplace and whether the condition shares features with idiopathic environmental intolerance. Methods: We investigated 12 patients with indoor aire-related work disability. The examinations included somatic, psychological, and psychiatric evaluations as well as investigations of the autonomic nervous system, cortisol measurements, lung function, and allergy tests. We evaluated well-being, health, disability, insomnia, pain, anxiety, depression, and burnout via questionnaires. Results: The mean symptom history was 10.5 years; for disabling symptoms, 2.7 years. Eleven patients reported reactions triggered mainly by indoor molds, one by fragrances only. Ten reported sensitivity to odorous chemicals, and three, electric devices. Nearly all had co-occurrent somatic and psychiatric diagnoses and signs of pain, insomnia, burnout, and/or elevated sympathetic responses. Avoiding certain environments had led to restrictions in several life areas. On self-assessment scales, disability showed higher severity and anxiety showed lower severity than in physician assessments. Conclusion: No medical cause was found to explain the disability. Findings support that the condition is a form of idiopathic environmental intolerance and belongs to functional somatic syndromes. Instead of endless avoidance, rehabilitation approaches of functional somatic syndromes are applicable.

키워드

참고문헌

  1. Bluyssen P, Roda C, Mandin C, Fossati S, Carrer P, de Kluizenaar Y, Mihucz VG, de Oliveira Fernandes E, Bartzis J. Self-reported health and comfort in 'modern'office buildings: first results from the European OFFICAIR study. Indoor Air 2016;26(2):298-317. https://doi.org/10.1111/ina.12196
  2. Edvardsson B, Stenberg B, Bergdahl J, Eriksson N, Linden G, Widman L. Medical and social prognoses of non-specific building-related symptoms (Sick Building Syndrome): a follow-up study of patients previously referred to hospital. Int Arch Occup Environ Health 2008;81(7):805-12. https://doi.org/10.1007/s00420-007-0267-z
  3. Karvala K, Nordman H, Luukkonen R, Uitti J. Asthma related to workplace dampness and impaired work ability. Int Arch Occup Environ Health 2014;87(1):1-11.. https://doi.org/10.1007/s00420-012-0830-0.
  4. Redlich CA, Sparer J, Cullen MR. Sick-building syndrome. Lancet 1997;349(9057):1013-6. https://doi.org/10.1016/S0140-6736(96)07220-0
  5. Vuokko A, Selinheimo S, Sainio M, Suojalehto H, Jarnefelt H, Virtanen M, Kallio E, Hublin C, Karvala K. Decreased work ability associated to indoor air problems-An intervention (RCT) to promote health behavior. Neurotoxicology 2015;49:59-67. https://doi.org/10.1016/j.neuro.2015.04.010
  6. Skovbjerg S, Brorson S, Rasmussen A, Johansen JD, Elberling J. Impact of self-reported multiple chemical sensitivity on everyday life: a qualitative study. Scand J Public Health 2009;37(6):621-6. https://doi.org/10.1177/1403494809105430
  7. Watanabe M, Tonori H, Aizawa Y. Multiple chemical sensitivity and idiopathic environmental intolerance (part one). Environ Health Prev Med 2003;7(6):264-72. https://doi.org/10.1007/BF02908885
  8. WHO (World Health Organisation). Indoor air pollutants: exposure and health effects. Copenhagen; WHO regional office for europe. Euro Rep Stud 1983;78.
  9. Norback D. An update on sick building syndrome. Curr Opin Allergy Clin Immunol 2009;9(1):55-9. https://doi.org/10.1097/ACI.0b013e32831f8f08
  10. Soderholm A, Ohman A, Stenberg B, Nordin S. Experience of living with nonspecific building-related symptoms. Scand J Psychol 2016;57(5):406-12. https://doi.org/10.1111/sjop.12319
  11. Van den Bergh O, Brown RJ, Petersen S, Witthoft M. Idiopathic environmental intolerance: a comprehensive model. Clin Psychol Sci 2017;5(3):551-67. https://doi.org/10.1177/2167702617693327
  12. Watanabe M, Tonori H, Aizawa Y. Multiple chemical sensitivity and idiopathic environmental intolerance (part two). Environ Health Prev Med 2003;7(6):273-82. https://doi.org/10.1007/BF02908886
  13. IPCS/WHO (International Programme on Chemical Safety/World Health Organisation). Conclusions and recommendations of a workshop on multiple chemical sensitivities (MCS). Regul Toxicol Pharmacol 1996;24:188-9. https://doi.org/10.1006/rtph.1996.0095
  14. Hetherington L, Battershill J. Review of evidence for a toxicological mechanism of idiopathic environmental intolerance. Hum Exp Toxicol 2013;32(1):3-17. https://doi.org/10.1177/0960327112457189
  15. Rubin GJ, Munshi JD, Wessely S. Electromagnetic hypersensitivity: a systematic review of provocation studies. Psychosom Med 2005;67(2):224-32. https://doi.org/10.1097/01.psy.0000155664.13300.64
  16. MCS Consensus Conference. Multiple chemical sensitivity: a 1999 consensus. Arch Environ Health 1999;54(3):147-9. https://doi.org/10.1080/00039899909602251
  17. Lacour M, Zunder T, Schmidtke K, Vaith P, Scheidt C. Multiple chemical sensitivity syndrome (MCS)-suggestions for an extension of the U.S. MCS-case definition. Int J Hyg Environ Health 2005;208(3):141-51. https://doi.org/10.1016/j.ijheh.2005.01.017
  18. Dantoft TM, Andersson L, Nordin S, Skovbjerg S. Chemical intolerance. Curr Rheumatol Rev 2015;11(2):167-84. https://doi.org/10.2174/157339711102150702111101
  19. Berg ND, Linneberg A, Dirksen A, Elberling J. Prevalence of self-reported symptoms and consequences related to inhalation of airborne chemicals in a Danish general population. Int Arch Occup Environ Health 2008;81(7):881-7. https://doi.org/10.1007/s00420-007-0282-0
  20. Vuokko A, Karvala K, Lampi J, Keski-Nisula L, Pasanen M, Voutilainen R, Pekkanen J, Sainio M. Environmental intolerance, symptoms and disability among fertile-aged women. Int J Environ Res Public Health 2018;15(2):293. https://doi.org/10.3390/ijerph15020293
  21. Bornschein S, Forstl H, Zilker T. Idiopathic environmental intolerances (formerly multiple chemical sensitivity) psychiatric perspectives. J Intern Med 2001;250(4):309-21. https://doi.org/10.1046/j.1365-2796.2001.00870.x
  22. Katerndahl DA, Bell IR, Palmer RF, Miller CS. Chemical intolerance in primary care settings: prevalence, comorbidity, and outcomes. Ann Fam Med 2012;10(4):357-65. https://doi.org/10.1370/afm.1346
  23. Blanco EL, Ferrando JP, Enriquez MR, Gento LA, Coll JS, Portell MRP. Multiple chemical sensitivity: clinical evaluation of the severity and psychopathological profile. Med Clin 2016;146(3):108-11 (English Edition). https://doi.org/10.1016/j.medcli.2015.09.016
  24. Karvala K, Uitti J, Luukkonen R, Nordman H. Quality of life of patients with asthma related to damp and moldy work environments. Scand J Work Environ Health 2013;39(1):96-105. https://doi.org/10.5271/sjweh.3289
  25. Al-Ahmad M, Manno M, Ng V, Ribeiro M, Liss GM, Tarlo SM. Symptoms after mould exposure including Stachybotrys chartarum, and comparison with darkroom disease. Allergy 2010;65(2):245-55.. https://doi.org/10.1111/j.1398-9995.2009.02157.x.
  26. Tuomi K, Ilmarinen J, Jahkola A, Katajarinne L, Tulkki A. Work ability index. Helsinki: Finnish Institute of Occupational Health; 1998.
  27. Goldman HH, Skodol AE, Lave TR. Revising axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry 1992;149(9):1148-56. https://doi.org/10.1176/ajp.149.9.1148
  28. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol 1996;11(3):89-95.
  29. Shirom A, Melamed S. A comparison of the construct validity of two burnout measures in two groups of professionals. Int J Stress Manag 2006;13(2):176-200. https://doi.org/10.1037/1072-5245.13.2.176
  30. Quanjer PH, Lebowitz MD, Gregg I, Miller MR, Pedersen OF. Peak expiratory flow: conclusions and recommendations of a working party of the european respiratory society. Eur Respir J Suppl 1997;24:2s-8s.
  31. ATS/ERS (American Thoracic Society/European Respiratory Society). ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 2005;171(8):912-30. https://doi.org/10.1164/rccm.200406-710ST
  32. Sovijarvi AR, Malmberg LP, Reinikainen K, Rytila P, Poppius H. A rapid dosimetric method with controlled tidal breathing for histamine challenge. Repeatability and distribution of bronchial reactivity in a clinical material. Chest 1993;104(1):164-70. https://doi.org/10.1378/chest.104.1.164
  33. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P, Murray JJ, Pendergraft TB. Development of the asthma control test: a survey for assessing asthma control. The J Allergy Clin Immunol 2004;113(1):59-65. https://doi.org/10.1016/j.jaci.2003.09.008
  34. Piha SJ, Seppanen A. Observations based on 10-years' experience of non-invasive cardiovascular reflex testing of autonomic function from a rehabilitation research centre. Clin Auton Res 1991;1(4):289-96. https://doi.org/10.1007/BF01819834
  35. Nunan D, Sandercock GR, Brodie DA. A quantitative systematic review of normal values for short-term heart rate variability in healthy adults. Pacing Clin Electrophysiol 2010;33(11):1407-17. https://doi.org/10.1111/j.1540-8159.2010.02841.x
  36. Laitinen T, Niskanen L, Geelen G, Lansimies E, Hartikainen J. Age dependency of cardiovascular autonomic responses to head-up tilt in healthy subjects. J Appl Physiol 2004;96(6):2333-40.. https://doi.org/10.1152/japplphysiol.00444.2003.
  37. Vansteenkiste J, Rochette F, Demedts M. Diagnostic tests of hyperventilation syndrome. Eur Respir J 1991;4(4):393-9.
  38. Firstbeat Technologies Ltd. Stress and recovery analysis method based on 24-hour heart rate variability; 2014 [cited 2019 Jan 10]. Available from: https://assets.firstbeat.com/firstbeat/uploads/2015/11/Stress-and-recovery_white-paper_20145.pdf.
  39. Teisala T, Mutikainen S, Tolvanen A, Rottensteiner M, Leskinen T, Kaprio J, Kolehmainen M, Rusko H, Kujala UM. Associations of physical activity, fitness, and body composition with heart rate variability-based indicators of stress and recovery on workdays: a cross-sectional study. J Occup Med Toxicol 2014;9(1):16.. https://doi.org/10.1186/1745-6673-9-16.
  40. Vreeburg SA, Zitman FG, van Pelt J, DeRijk RH, Verhagen JCM, van Dyck R, Hoogendijk WJG, Smit JH, Penninx BWJH. Salivary cortisol levels in persons with and without different anxiety disorders. Psychosom Med 2010;72(4):340-7. https://doi.org/10.1097/PSY.0b013e3181d2f0c8
  41. First MB, Spitzer RL, Gibbon M. Structured clinical interview for DSM-IV Axis I disorders. Washington DC: American Psychiatric Press; 1997.
  42. Moritz S, Meier B, Kloss M, Jacobsen D, Wein C, Fricke S, Hand I. Dimensional structure of the yale-Brown obsessive-compulsive scale (Y-BOCS). Psychiatry Res 2002;109(2):193-9. https://doi.org/10.1016/S0165-1781(02)00012-4
  43. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. The Br J Psychiatry 1979;134:382-9. https://doi.org/10.1192/bjp.134.4.382
  44. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166(10):1092-7. https://doi.org/10.1001/archinte.166.10.1092
  45. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56(6):893-7. https://doi.org/10.1037/0022-006X.56.6.893
  46. Campbell-Sills L, Norman SB, Craske MG, Sullivan G, Lang AJ, Chavira DA, Bystritsky A, Sherbourne C, Roy-Byrne P, Stein MB. Validation of a brief measure of anxiety-related severity and impairment: the Overall anxiety severity and impairment scale (OASIS). J Affect Disord 2009;112(1-3):92-101. https://doi.org/10.1016/j.jad.2008.03.014
  47. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16(9):606-13. https://doi.org/10.1046/j.1525-1497.2001.016009606.x
  48. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-71. https://doi.org/10.1001/archpsyc.1961.01710120031004
  49. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive therapy of depression. New York (NY): Guilford Press; 1979.
  50. Morin CM. Insomnia: psychological assessment and management. New York (NY): Guilford Press; 1993.
  51. Miller CS, Prihoda TJ. The Environmental Exposure and Sensitivity Inventory (EESI): a standardized approach for measuring chemical intolerances for research and clinical applications. Toxicol Ind Health 1999;15(3-4):370-85. https://doi.org/10.1177/074823379901500311
  52. Das-Munshi J, Rubin GJ, Wessely S. Multiple chemical sensitivities: review. Curr Opin Otolaryngol Head Neck Surg 2007;15(4):274-80. https://doi.org/10.1097/MOO.0b013e328259c360
  53. Bailer J, Witthoft M, Rist F. Modern health worries and idiopathic environmental intolerance. J Psychosom Res 2008;65(5):425-33. https://doi.org/10.1016/j.jpsychores.2008.05.006
  54. Rief W, Burton C, Frostholm L, Henningsen P, Kleinstauber M, Kop WJ, Lowe B, Martin A, Malt U, Rosmalen J, Schroder A, Shedden-Mora M, Toussaint A, Van der Feltz-Cornelis C., EURONET-SOMA Group. Core outcome domains for clinical trials on somatic symptom disorder, bodily distress disorder, and functional somatic syndromes: european network on somatic symptom disorders recommendations. Psychosom Med 2017;79(9):1008-15. https://doi.org/10.1097/PSY.0000000000000502
  55. Yunus MB. Editorial review (thematic issue: an update on central sensitivity syndromes and the issues of nosology and psychobiology). Curr Rheumatol Rev 2015;11:70-85. https://doi.org/10.2174/157339711102150702112236
  56. Baliatsas C, van Kamp I, Hooiveld M, Yzermans J, Lebret E. Comparing non-specific physical symptoms in environmentally sensitive patients: prevalence, duration, functional status and illness behavior. J Psychosom Res 2014;76(5):405-13. https://doi.org/10.1016/j.jpsychores.2014.02.008
  57. Palmquist E, Claeson AS, Neely G, Stenberg B, Nordin S. Overlap in prevalence between various types of environmental intolerance. Int J Hyg Environ Health 2014;217(4-5):427-34.. https://doi.org/10.1016/j.ijheh.2013.08.005.
  58. Laukkala T, Heikinheimo S, Vuokko A, Junttila IS, Tuisku K. Subjective and objective measures of function and return to work: an observational study with a clinical psychiatric cohort. Soc Psychiatry Psychiatr Epidemiol 2018;53(5):537-40. https://doi.org/10.1007/s00127-017-1479-5
  59. Weiss EM, Singewald E, Baldus C, Hofer E, Marksteiner J, Nasrouei S, Ruepp B, Kapfhammer H-P, Fitz W, Mai C, Bauer A, Papousek I, Holzer P. Differences in psychological and somatic symptom cluster score profiles between subjects with Idiopathic environmental intolerance, major depression and schizophrenia. Psychiatry Res 2017;249:187-94. https://doi.org/10.1016/j.psychres.2016.12.057
  60. Eliasen M, Schroder A, Fink P, Kreiner S, Dantoft TM, Poulsen CH, Petersen MW, Eplov LF, Skovbjerg S, Jorgensen T. A step towards a new delimitation of functional somatic syndromes: a latent class analysis of symptoms in a population-based cohort study. J Psychosom Res 2018;108:102-17. https://doi.org/10.1016/j.jpsychores.2018.03.002
  61. Mariman A, Delesie L, Tobback E, Hanoulle I, Sermijn E, Vermeir P, Pevernagie D, Vogelaers D. Undiagnosed and comorbid disorders in patients with presumed chronic fatigue syndrome. J Psychosom Res 2013;75(5):491-6. https://doi.org/10.1016/j.jpsychores.2013.07.010
  62. Ekstedt M, Soderstrom M, Akerstedt T, Nilsson J, Sondergaard H-P, Aleksander P. Disturbed sleep and fatigue in occupational burnout. Scand J Work Environ Health 2006;32(2):121-31. https://doi.org/10.5271/sjweh.987
  63. Salvagioni DAJ, Melanda FN, Mesas AE, Gonzalez AD, Gabani FL, de Andrade SM. Physical, psychological and occupational consequences of job burnout: a systematic review of prospective studies. PLoS One 2017;12(10):e0185781. https://doi.org/10.1371/journal.pone.0185781
  64. Van den Bergh O, Witthoft M, Petersen S, Brown RJ. Symptoms and the body: taking the inferential leap. Neurosci Biobehav Rev 2017;74:185-203. https://doi.org/10.1016/j.neubiorev.2017.01.015
  65. Finell E, Seppala T. Indoor air problems and experiences of injustice in the workplace: a quantitative and a qualitative study. Indoor Air 2018;28(1):125-34. https://doi.org/10.1111/ina.12409
  66. Karvala K, Sainio M, Palmquist E, Nyback MH, Nordin S. Prevalence of various environmental intolerances in a Swedish and Finnish general population. Environ Res 2018;161:220-8. https://doi.org/10.1016/j.envres.2017.11.014

피인용 문헌

  1. Psychosocial treatments for employees with non-specific and persistent physical symptoms associated with indoor air: A randomised controlled trial with a one-year follow-up vol.131, 2019, https://doi.org/10.1016/j.jpsychores.2020.109962
  2. VOC and carbonyl compound emissions of a fiberboard resulting from a coriander biorefinery: comparison with two commercial wood-based building materials vol.27, pp.14, 2020, https://doi.org/10.1007/s11356-020-08101-y